Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

For First US OTC Birth Control Application, FDA Extends Time For Advisory Panel Discussion

Mar 29 2023

• By Lauren Nardella

• Source: Shutterstock

Related Content

Perrigo Results Mirror Previous Year After 2022 Made Momentous With OTC Contraceptive Play

Feb 28 2023

US FDA Has 10 Months To Provide Answer On Perrigo/HRA OTC Oral Contraceptive Application

Jul 12 2022

Political Winds, Like Previous Storms Over US FDA Decisions, Stir Around OTC Contraceptive Proposal

Aug 25 2022

US FDA Requests More Information, Needs More Time To Review Birth Control OTC Switch Proposal

Oct 27 2022

Related Companies

Perrigo Company PLC

Additional Topics

International United States Prescription To OTC Switch Advisory Committees FDA Business Strategies Companies Commercial Compliance Consumer Drug Approval Standards Drug Review Drug Safety Ingredients OTC Drugs Policy Politics Regulation Research & Development

More from Rx-to-OTC Switch

More from Health

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window